Detalhe da pesquisa
1.
Model-Based Phase 3 Dose Selection for HIV-1 Attachment Inhibitor Prodrug BMS-663068 in HIV-1-Infected Patients: Population Pharmacokinetics/Pharmacodynamics of the Active Moiety, BMS-626529.
Antimicrob Agents Chemother
; 60(5): 2782-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26902761
2.
Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects.
Antimicrob Agents Chemother
; 59(7): 3816-22, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870057
3.
The pharmacokinetics of peginterferon lambda-1a following single dose administration to subjects with impaired renal function.
Br J Clin Pharmacol
; 80(3): 515-24, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807956
4.
Population Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356 and Its Active Metabolite Following Single and Multiple Oral Administration in Healthy Individuals and Patients with Parkinson's Disease.
Clin Pharmacol Drug Dev
; 13(5): 549-559, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178727
5.
Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356 Following Single and Multiple Oral Administration in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 12(8): 801-809, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683291
6.
Population Pharmacokinetics and Exposure - Safety Analyses of Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma.
J Clin Pharmacol
; 59(3): 364-373, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339279
7.
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers.
Cancer Chemother Pharmacol
; 83(4): 705-715, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666395
8.
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
J Clin Pharmacol
; 57(2): 235-246, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27432796
9.
Mechanisms of Hyperbilirubinemia During Peginterferon Lambda-1a Therapy for Chronic Hepatitis C Infection: A Retrospective Investigation.
J Interferon Cytokine Res
; 36(11): 644-651, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27710263
10.
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.
Springerplus
; 5(1): 1365, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27588258
11.
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 2: Exposure-response analyses for efficacy and safety variables.
J Clin Pharmacol
; 55(1): 73-80, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042797
12.
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates.
J Clin Pharmacol
; 55(1): 63-72, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043197
13.
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients.
Bioanalysis
; 7(9): 1093-106, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26039807
14.
Effect of St John's wort on imatinib mesylate pharmacokinetics.
Clin Pharmacol Ther
; 76(4): 323-9, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15470331
15.
Determination of trimethoprim in low-volume human plasma by liquid chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci
; 807(2): 301-5, 2004 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15203044
16.
Simplified method for determination of rosiglitazone in human plasma.
J Chromatogr B Analyt Technol Biomed Life Sci
; 803(2): 317-20, 2004 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15063342
17.
Pyrosequencing method for genotyping cytochrome P450 CYP2C8 and CYP2C9 enzymes.
Clin Chem
; 50(12): 2392-5, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15563491